Replication of the human immunodeficiency virus type 1 (HIV-1) is inhibited
by interferons (IFNs), in part through activity of the IFN-inducible prote
in kinase PKR, To escape this antiviral effect, HIV-1 has developed strateg
ies for blocking PKR function. We have previously shown that the HIV-1 Tat
protein can associate with PKR in vitro and in vivo and inhibit PKR activit
y. Here we present evidence that Tat can inhibit PKR activity by both RNA-d
ependent and RNA-independent mechanisms. Tat inhibited PKR activation by th
e non-RNA activator heparin, and also suppressed PKR basal level autophosph
orylation in the absence of RNA. However, when Tat and dsRNA were preincuba
ted, the amount of Tat required to inhibit PKR activation by dsRNA depended
on the dsRNA concentration. In addition to its function in vitro, Tat can
also reverse translation inhibition mediated by PKR in COS cells. The Tat a
mino acid sequence required for interaction with PKR was mapped to residues
40-58, overlapping the hydrophobic core and basic region of HIV-1 Tat. Ali
gnment of amino acid sequences of Tat and eIF-2 alpha indicates similarity
between the Tat-PKR binding region and the residues around the eIF-2 alpha
phosphorylation site, suggesting that Tat and eIF-2 alpha may bind to the s
ame site on PKR. (C) 2000 Academic Press.